These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 32562788)
1. RapidPlan for Knowledge-Based Planning of Malignant Pleural Mesothelioma. Dumane VA; Tam J; Lo YC; Rosenzweig KE Pract Radiat Oncol; 2021; 11(2):e219-e228. PubMed ID: 32562788 [TBL] [Abstract][Full Text] [Related]
2. Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma. Yorke ED; Jackson A; Kuo LC; Ojo A; Panchoo K; Adusumilli P; Zauderer MG; Rusch VW; Shepherd A; Rimner A Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):61-69. PubMed ID: 28816162 [TBL] [Abstract][Full Text] [Related]
3. Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs. Thompson MR; Dumane VA; Lazarev SA; Zia Y; Rosenzweig KE Pract Radiat Oncol; 2019 May; 9(3):e331-e337. PubMed ID: 30654090 [TBL] [Abstract][Full Text] [Related]
4. Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients. Franceschini D; Cozzi L; Fogliata A; Marini B; Di Cristina L; Dominici L; Spoto R; Franzese C; Navarria P; Comito T; Reggiori G; Tomatis S; Scorsetti M Radiat Oncol; 2022 Aug; 17(1):150. PubMed ID: 36028862 [TBL] [Abstract][Full Text] [Related]
5. Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints. Leitzen C; Wilhelm-Buchstab T; Stumpf S; Heimann M; Koch D; Schmeel C; Simon B; Vornholt S; Garbe S; Röhner F; Schoroth F; Schild HH; Schüller H; Müdder T Strahlenther Onkol; 2019 Jul; 195(7):668-676. PubMed ID: 30915490 [TBL] [Abstract][Full Text] [Related]
6. Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma. Ulger S; Cetin E; Catli S; Sarac H; Kilic D; Bora H Technol Cancer Res Treat; 2017 Jun; 16(3):332-338. PubMed ID: 28462689 [TBL] [Abstract][Full Text] [Related]
7. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy. Krayenbuehl J; Oertel S; Davis JB; Ciernik IF Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793 [TBL] [Abstract][Full Text] [Related]
8. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer. Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296 [TBL] [Abstract][Full Text] [Related]
9. A pilot study of volumetric-modulated arc therapy for malignant pleural mesothelioma. Runxiao L; Yankun C; Lan W J Appl Clin Med Phys; 2016 Mar; 17(2):139-144. PubMed ID: 27074478 [TBL] [Abstract][Full Text] [Related]
10. SU-E-T-595: Comparison of Volumetric Modulated Arc Therapy (VMAT) and Static Intensity Modulated Radiotherapy (IMRT) for Malignant Pleural Mesothelioma in Patients with Intact Lungs/Post Pleurectomy. Dumane V; Yorke E; Rimner A; RosenzweigG K Med Phys; 2012 Jun; 39(6Part19):3842. PubMed ID: 28517082 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Multi-Criteria Optimization-based Trade-Off exploration in combination with RapidPlan for head & neck radiotherapy planning. Miguel-Chumacero E; Currie G; Johnston A; Currie S Radiat Oncol; 2018 Nov; 13(1):229. PubMed ID: 30470254 [TBL] [Abstract][Full Text] [Related]
13. Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience. Franceschini D; De Rose F; Cozzi S; Renna I; Franzese C; Di Brina L; Navarria P; D'Agostino GR; Mancosu P; Tomatis S; Scorsetti M Clin Lung Cancer; 2020 Jan; 21(1):86-93. PubMed ID: 31563545 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Planning Quality and Efficiency Between Conventional and Knowledge-based Algorithms in Nasopharyngeal Cancer Patients Using Intensity Modulated Radiation Therapy. Chang ATY; Hung AWM; Cheung FWK; Lee MCH; Chan OSH; Philips H; Cheng YT; Ng WT Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):981-990. PubMed ID: 27302513 [TBL] [Abstract][Full Text] [Related]
15. Restricted field IMRT dramatically enhances IMRT planning for mesothelioma. Allen AM; Schofield D; Hacker F; Court LE; Czerminska M Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1587-92. PubMed ID: 17892915 [TBL] [Abstract][Full Text] [Related]
16. Tomotherapy PET-guided dose escalation: A dosimetric feasibility study for patients with malignant pleural mesothelioma. Maggio A; Cutaia C; Di Dia A; Bresciani S; Miranti A; Poli M; Del Mastro E; Garibaldi E; Gabriele P; Stasi M Strahlenther Onkol; 2016 Feb; 192(2):102-8. PubMed ID: 26453534 [TBL] [Abstract][Full Text] [Related]
17. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382 [TBL] [Abstract][Full Text] [Related]
18. Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy. Krayenbuehl J; Hartmann M; Lomax AJ; Kloeck S; Hug EB; Ciernik IF Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):628-34. PubMed ID: 20385451 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a knowledge-based planning solution for head and neck cancer. Tol JP; Delaney AR; Dahele M; Slotman BJ; Verbakel WF Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):612-20. PubMed ID: 25680603 [TBL] [Abstract][Full Text] [Related]
20. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma. Kishan AU; Cameron RB; Wang PC; Alexander S; Qi SX; Low DA; Kupelian PA; Steinberg ML; Lee JM; Selch MT; Lee P Pract Radiat Oncol; 2015; 5(6):366-73. PubMed ID: 26432677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]